Ngozi Okonjo-Iweala, WTO Director-General (Salvatore Di Nolfi/Keystone via AP Images)

A wa­tered-down Covid-19 vac­cine IP waiv­er nears the fin­ish line: Will it ac­tu­al­ly ex­pand sup­plies?

The US, EU, In­dia, and South Africa have forged at least a pre­lim­i­nary agree­ment around an in­tel­lec­tu­al prop­er­ty (IP) waiv­er at the World Trade Or­ga­ni­za­tion — a move the four coun­tries hope will help oth­ers at­tain more Covid-19 vac­cine sup­plies, even as ad­vo­cates have said the waiv­er won’t do much.

The waiv­er, ac­cord­ing to a leaked draft ver­sion, will ap­ply to any de­vel­op­ing coun­try par­tic­i­pat­ing in the WTO that ex­port­ed less than 10% of the world’s Covid-19 vac­cine dos­es in 2021 (i.e., not Chi­na or Rus­sia, but In­dia could use it).

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.